Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT
· Real-Time Price · USD
7.68
-0.99 (-11.42%)
At close: Aug 15, 2025, 3:59 PM
7.83
1.95%
After-hours: Aug 15, 2025, 07:47 PM EDT
Sagimet Biosciences Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Mar 31, 2021 |
PE Ratio | -5.91 | -1.44 | -2.24 | -1.52 | -3.11 | -5.73 | -3.02 | -6.3 | -13.03 | -13.42 | -12.29 | -11.84 | -12.45 | -10.12 | -15.94 |
PEG Ratio | 0.14 | -0.12 | -0.2 | -0.02 | -0.36 | 0.12 | -0.11 | -0.49 | -3.91 | 2.15 | 2.09 | -1.89 | 0.69 | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 80.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.88 | 0.76 | 0.93 | 0.52 | 0.55 | 0.80 | 1.08 | 1.64 | -1.78 | -1.84 | -1.89 | n/a | n/a | 6.27 | -2.52 |
P/FCF Ratio | -26.96 | -7.22 | -13.14 | -4.55 | -17.9 | -24.46 | -13.92 | -41.28 | -61.83 | -49.93 | -47.45 | -56.73 | -57.62 | -75.81 | -72.13 |
P/OCF Ratio | -26.96 | -7.22 | -13.14 | -4.55 | -17.9 | -24.46 | -13.92 | -41.28 | -61.83 | -49.93 | -47.45 | -56.73 | -57.62 | -75.81 | -72.13 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.94 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 | n/a | n/a | n/a | -0.00 |
Quick Ratio | 17.55 | 20.34 | 34.30 | 38.41 | 29.11 | 43.12 | 17.09 | 20.36 | 4.04 | 5.12 | 6.21 | n/a | n/a | n/a | 24.64 |
Current Ratio | 17.55 | 20.34 | 34.30 | 38.41 | 29.11 | 43.12 | 17.09 | 20.36 | 4.04 | 5.12 | 6.21 | n/a | n/a | n/a | 24.64 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.08 | -0.13 | -0.1 | -0.09 | -0.04 | -0.03 | -0.09 | -0.06 | 0.03 | 0.03 | 0.04 | n/a | n/a | -0.15 | 0.04 |
Return on Assets | -0.08 | -0.12 | -0.1 | -0.08 | -0.04 | -0.03 | -0.08 | -0.06 | -0.32 | -0.24 | -0.22 | n/a | n/a | n/a | -0.07 |
Return on Invested Capital | -0.09 | -0.14 | -0.12 | -0.1 | -0.06 | -0.05 | -0.1 | -0.08 | -0.43 | -0.31 | -0.26 | n/a | n/a | n/a | -0.06 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.98 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.73 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.73 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |